ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 182.50
-11.50 (-5.93%)
Oct 30, 2026, 10:29 AM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 13.08 billion as of October 29, 2026. It is the 15,335th most valuable company in the world and the 556th biggest in Taiwan. Its market cap has increased by 215.19% in one year.
Market Cap
13.08B
Enterprise Value
12.20B
Revenue
52.76M
Global Rank
Country Rank
#556 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 13.08B, an increase of 1,220.61%. That is a compound annual growth rate of 63.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 13.40B | 231.77% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 16.67B |
| Medigen Vaccine Biologics | 16.24B |
| Ever Supreme Bio Technology | 15.16B |
| EirGenix | 14.66B |
| Steminent Biotherapeutics | 14.06B |
| Gongwin Biopharm Holdings | 13.99B |
| AP Biosciences | 12.87B |
| Lumosa Therapeutics | 11.92B |